Brought to you by 
Arthrex to sell Vomaris' Procellera wound therapy worldwide
05 Feb 2015
Executive Summary
Vomaris Innovations Inc. granted Arthrex Inc. exclusive global rights to sell its Procellera wound care technology in human and veterinary orthopedic and sports medicines markets.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Arthrex to sell Vomaris' Procellera wound therapy worldwide
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice